We are live on ! Find out more
Antipodes Partners

Antipodes Partners Portfolio holdings

AUM $5.46B Turnover 36.94%
1-Year Est. Return 26.64%
This Fund
S&P 500
This Quarter Est. Return
+9.77%
1 Year Est. Return
+26.64%
3 Year Est. Return
+96.4%
5 Year Est. Return
+160.76%
10 Year Est. Return
–
AUM
$4.46B
AUM Growth
+$1.23B
Cap. Flow
+$903M
Cap. Flow %
20.27%
Top 10 Hldgs %
37.6%
Holding
139
New
33
Increased
39
Reduced
42
Closed
23
Avg Time Held Equity + Options
1 year
Top 10 Avg Time Held Equity + Options
1.5 years
Top 20 Avg Time Held Equity + Options
1.5 years
Avg Time Held Equity only
1 year
Top 10 Avg Time Held Equity only
1.5 years
Top 20 Avg Time Held Equity only
1.5 years

Top Buys

Rank Stock Value
1
FER icon
Ferrovial N.V. Ordinary Shares
FER
+$167M
2
EXC icon
Exelon
EXC
+$156M
3
AEE icon
Ameren
AEE
+$137M
4
SRE icon
Sempra
SRE
+$136M
5
CCI icon
Crown Castle
CCI
+$128M

Sector Composition

Rank Sector Weight
1 Utilities 29.08%
2 Healthcare 12.43%
3 Technology 11.96%
4 Financials 8.08%
5 Materials 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LUMN icon
126
PUT
Lumen Technologies, Inc. Common Stock
LUMN
$5.02B
– –
-113
Closed -$113 –
MGNI icon
127
Magnite
MGNI
$3.51B
– –
-9,162
Closed -$221K –
MU icon
128
Micron Technology
MU
$1.05T
– –
-403,540
Closed -$49.7M –
NTR icon
129
Nutrien
NTR
$33.2B
– –
-460,269
Closed -$26.8M –
NVCR icon
130
NovoCure
NVCR
$1.68B
– –
-1,119
Closed -$19.9K –
PHM icon
131
Pultegroup
PHM
$21.5B
– –
-151,611
Closed -$16M –
QCOM icon
132
Qualcomm
QCOM
$191B
– –
-10,086
Closed -$1.61M –
SABR icon
133
Sabre
SABR
$722M
– –
-87,855
Closed -$278K –
SMWB icon
134
Similarweb
SMWB
$776M
– –
-17,510
Closed -$137K –
SPRY icon
135
ARS Pharmaceuticals
SPRY
$405M
– –
-2,201
Closed -$38.4K –
T icon
136
AT&T
T
$161B
– –
-324,832
Closed -$9.4M –
VRTX icon
137
Vertex Pharmaceuticals
VRTX
$129B
– –
-241
Closed -$107K –
YMM icon
138
Full Truck Alliance
YMM
$9.15B
– –
-68,035
Closed -$804K –
GEV icon
139
GE Vernova
GEV
$247B
– –
-34,137
Closed -$18.1M –

Similar funds

Antipodes Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Antipodes Partners held 139 positions worth $4.46B, up 38% from $3.22B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Antipodes Partners deployed $903M of net new capital in Q3 2025, opening 33 new positions and adding to 39 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 3,097,701 shares worth $176M.

By sector, the portfolio is most concentrated in Utilities at 29% of assets, up from 3.7% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $108M trimmed.

  • Antipodes Partners's largest Q3 2025 buy was Ferrovial N.V. Ordinary Shares: 3,097,701 shares worth $176M.
  • Antipodes Partners added most to Exelon in Q3 2025, an estimated $156M increase.
  • Antipodes Partners's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $108M.
  • Antipodes Partners fully exited Micron Technology in Q3 2025, selling an estimated $49.7M.
  • Antipodes Partners's ten largest holdings make up 38% of its $4.46B portfolio in Q3 2025.
  • Antipodes Partners opened 33 new positions and closed 23 in Q3 2025.
  • Antipodes Partners's portfolio value rose 38% quarter-over-quarter to $4.46B.

Based on Antipodes Partners's 13F filing for Q3 2025, filed 10 Nov 2025.